BackCardiovascular Systems Overview

Cardiovascular Systems Net Income

Cardiovascular Systems's net income is $-38M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$7.89M
12.03% YoY

As of Dec 2022

Annual Net Income (TTM)

-$37.87M
31.15% YoY

Trailing 12 months ending Dec 2022

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Cardiovascular Systems (CSII) FAQ

As of the most recent data (December 2022), CSII shows a net income of $-38M. That compares with $-29M in the prior-year period — down 31.1% year over year. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSII's net income is now $-38M (was $-29M) — a 31.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cardiovascular Systems is outperforming or lagging.

The Healthcare sector average net income is about $16B. Cardiovascular Systems is at $-38M, which is lower that average. That is roughly 100.2% below the sector mean. Use the comparison chart on this page to see how CSII stacks up against individual peers as well.

Tracking CSII's net income over time shows whether Cardiovascular Systems is scaling, shrinking, or reshaping that part of the business. The current reading is $-38M That compares with $-29M in the prior-year period — down 31.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has Cardiovascular Systems's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-38M) with ownership activity and broader fundamentals.